Piper Jaffray & Co. maintains a 'Neutral' rating on Mindray Medical (NYSE: MR), raises prices target from $20 to $31 ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE